Prompted by a finding that the angiotensin-receptor blocker losartan prevented cardiovascular events more effectively than atenolol in hypertensive patients with left ventricular hypertrophy ...

As for blood pressure reduction, the target of <140/90 mm Hg was achieved in only 49% of the losartan patients and 46% of the atenolol patients. Finally, the study group was diverse in inclusion ...